Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions.
Diabetes Information Center
Emergency Department Visits for Medication Harms Are Frequent
However, most common product type and intent of use associated with these visits vary by age.
Heart Health May Help Prevent Diabetes, Regardless of Genetics
At age 55 years, remaining lifetime risk of diabetes in the high genetic risk group was 23.5 percent for those in ideal cardiovascular health.
Controversies in the Diagnosis and Treatment of Gastroparesis
Researchers addressed common misconceptions regarding the diagnosis and treatment of gastroparesis.
Fish, Fatty Acid Supplements, and Post-Pregnancy Type 2 Diabetes Explored
Investigators assessed the relationship among lean or fatty fish intake, fatty acid supplements, and lowered severity of type 2 diabetes in women following pregnancy.
Risk Factors for MACE After First Acute Coronary Syndrome Identified
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Greater Weight Loss After Bariatric Surgery Tied to Diabetes Remission
Researchers assessed the amount of weight loss necessary to achieve initial remission of type 2 diabetes mellitus following bariatric surgery.
Type 2 Diabetes Remission Criteria Defined in ADA Consensus Statement
People diagnosed with type 2 diabetes can eventually achieve normal glucose levels. But whether or when this means a person is “in remission” was the subject of an international group of experts convened by the American Diabetes Association.
The Potential Dangers of Ketogenic Diets in Kidney Disease
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
Efpeglenatide Reduces Cardiovascular Events in Some Patients With Type 2 Diabetes
Investigators assessed the effect of efpeglenatide, an exendin-based glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes at increased risk for cardiovascular events.
SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
USPSTF Says Start Diabetes Screening at Age 35 for Those Overweight, Obese
Overweight or obese adults should be screened for prediabetes, type 2 diabetes and offered or referred for preventive interventions
Top July 2021 FDA Approvals
July 2021 FDA drug approvals include treatments for T2D in adolescents, trichomoniasis, and acne vulgaris, as well as a vaccine for pneumococcal diseases.
Increased Dietary Intake of L-Arginine Linked to Increased Risk for Type 2 Diabetes
Researchers studied the effect of dietary L-arginine on the incidence of type 2 diabetes.
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Approaches to Reduce Therapeutic Inertia in Diabetes Management
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
Bydureon BCise Approved for Adolescents With Type 2 Diabetes
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes
Researchers studied the effectiveness of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin without prandial insulin in primary care practices.
Many Patients With AMI Have Disturbed Glucose Metabolism but No History of Diabetes
One of the researchers’ goals was to investigate the association between newly detected disturbances of glucose metabolism and long-term prognosis after AMI.
Bariatric Gastric Bypass Surgery Alters Gut Microbiome in Adults With T2D and Mild Obesity
Researchers assessed how gut microbiota changes are associated with anthropometric, metabolic, and inflammatory profiles following metabolic surgery in adults with type 2 diabetes and mild obesity.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...